Ethiopia Healthcare System and U.S. Sector Cooperation

Ethiopia’s healthcare system remains under development and continues to face a dual burden of communicable and non-communicable diseases. While progress has been made in recent years, gaps persist in infrastructure, workforce capacity, and access to quality health services, particularly in rural and underserved areas. These challenges highlight the need for sustained investment, stronger institutions, and long-term system strengthening.

In December 2025, the U.S. government signed a Memorandum of Understanding committing up to $1.016 billion in grants, in addition to $150 million in performance-based funding. The agreement focuses on priority areas such as HIV/AIDS, tuberculosis, malaria, and polio control, as well as maternal and child health, disease surveillance, laboratory systems, health workforce training, and outbreak preparedness and response. This cooperation aligns with the U.S. “America First Global Health Strategy,” emphasizing accountability, efficiency, and measurable results.

The agreement builds on longstanding bilateral ties and reflects a strategic shift from NGO-driven assistance toward government-led implementation, particularly in the context of global funding constraints. It places strong emphasis on health system resilience, increased domestic financing, and sustainable outcomes. From a commercial perspective, the deal signals greater opportunities on the investment side as well as exports in the aforementioned areas. 

U.S. companies seeking to engage in Ethiopia’s health sector under this framework are encouraged to work closely with the Ethiopian Ministry of Health to explore collaboration mechanisms, implementation modalities, and priority investment areas.

For additional information, please reachout to Yemesrach.Kassu@trade.gov